rational
hsv
one
widespread
human
viral
pathogen
infect
larg
portion
human
popul
caus
sever
diseas
current
clinic
treatment
base
nucleosid
analogu
use
limit
due
drug
resist
side
effect
poor
bioavail
amp
identifi
potenti
antivir
agent
may
overcom
limit
therefor
screen
peptid
scorpionderiv
amp
librari
engin
one
candid
histidinerich
peptid
significantli
improv
antivir
activ
develop
potenti
method
venom
gland
cdna
librari
construct
scorpion
euscorpiop
validu
yunnan
provinc
china
six
put
amp
character
cdna
librari
synthes
peptid
screen
via
plaqueform
assay
determin
virucid
potenti
time
addit
experi
accord
infect
progress
use
identifi
mode
action
peptid
interest
histidinerich
modif
design
base
structur
analysi
peptid
helic
wheel
model
cd
spectroscopi
peptid
cellular
uptak
distribut
measur
flow
cytometri
confoc
microscopi
respect
result
peptid
found
high
clearanc
activ
plaqu
reduct
assay
exhibit
dosedepend
timedepend
inactiv
dosedepend
inhibit
attach
host
cell
howev
scarc
suppress
establish
infect
due
poor
cellular
uptak
design
modifi
four
histidinerich
deriv
peptid
enhanc
antivir
activ
lower
cytotox
deriv
peptid
suppress
establish
infect
one
peptid
strong
viral
inactiv
activ
enhanc
attach
inhibitori
activ
also
high
inhibitori
activ
intracellular
consist
improv
intracellular
uptak
distribut
confirm
confoc
microscopi
flow
cytometri
conclus
success
identifi
peptid
scorpion
venom
peptid
librari
design
histidinerich
deriv
significantli
improv
potenti
develop
drug
success
modif
provid
design
strategi
improv
bioavail
cellular
distribut
antivir
activ
peptid
agent
herp
simplex
viru
type
one
common
human
pathogen
infect
human
popul
human
natur
host
hsv
hsv
infect
almost
exclus
limit
epitheli
cell
peripher
nervou
system
pn
neuron
hsv
caus
diseas
rang
mild
condit
lethal
infect
includ
mucocutan
lesion
labiali
skin
herp
kerat
herp
enceph
licens
treatment
base
nucleosid
analogu
acyclovir
valacyclovir
famciclovir
howev
current
treatment
unabl
prevent
establish
latenc
reactiv
latent
viru
due
drug
resist
side
effect
poor
bioavail
associ
current
treatment
lack
effect
vaccin
discoveri
develop
novel
agent
still
urgent
recent
year
antimicrobi
peptid
amp
suggest
promis
strategi
develop
new
antihsv
agent
wide
varieti
organ
insect
mammal
amphibian
fish
plant
secret
amp
import
compon
innat
immun
system
peptid
exhibit
broad
inhibitori
activ
fungi
bacteria
parasit
virus
mani
amp
report
inhibitori
activ
hsv
infect
melittin
cecropin
magainin
scorpion
ancient
terrestri
creatur
live
earth
four
hundr
million
year
sake
predat
surviv
evolv
uniqu
venom
system
contain
neurotoxin
antimicrobi
peptid
enzym
compon
natur
amp
scorpion
venom
deriv
peptid
exhibit
attract
antivir
activ
peptid
studi
previou
report
recombin
peptid
scorpin
rscp
report
inhibit
replic
cell
natur
amphipath
peptid
directli
interact
hcv
viral
envelop
decreas
viral
infect
scorpion
venomderiv
synthet
peptid
exhibit
virucid
activ
measl
sarscov
influenza
virus
via
direct
interact
viru
envelop
also
inhibit
hbv
replic
vitro
vivo
activ
mitogenactiv
protein
kinas
mapk
pathway
reduc
express
hepatocyt
nuclear
factor
scorpion
venom
peptid
deriv
inhibit
direct
interact
viral
particl
histidinerich
mutant
anoth
scorpionderiv
peptid
show
significantli
enhanc
bioavail
antihcv
activ
two
scorpion
venom
peptid
inhibit
recent
scorpion
defensin
report
inhibit
hbv
replic
vitro
thu
scorpionderiv
amp
librari
rich
sourc
new
antivir
agent
still
await
util
studi
screen
scorpion
venom
peptid
identifi
inhibit
initi
infect
disrupt
initi
step
infect
hardli
suppress
establish
infect
specul
result
poor
cellular
uptak
sinc
introduc
histidin
residu
improv
peptid
helic
amphiphil
attempt
modifi
four
histidinerich
deriv
peptid
improv
cellular
uptak
intracellular
distribut
subsequ
antivir
activ
helic
amphiphil
peptid
character
circular
dichroism
cd
experi
show
modifi
peptid
exhibit
greater
inhibit
parent
peptid
especi
modifi
peptid
exert
lowest
cytotox
highest
activ
result
confoc
microscopi
flow
cytometri
analys
also
reveal
enhanc
cellular
uptak
dispers
cellular
distribut
cdna
librari
screen
e
validu
scorpion
collect
yunnan
provinc
china
previous
describ
gland
collect
day
electr
extract
venom
trizol
reagent
invitrogen
use
prepar
total
rna
poli
mrna
purifi
use
polya
tract
mrna
isol
system
promega
cdna
librari
construct
accord
specif
superscript
plasmid
system
cdna
librari
construct
kit
gibcobrl
cdna
clone
plasmid
transform
e
coli
cell
china
center
type
cultur
collect
cctcc
randomli
chosen
cdna
clone
sequenc
obtain
reliabl
represent
venom
gland
peptid
librari
peptid
gflgnlwegikt
qdynhdrdivppr
iaktalkvlpql
lwgeiwntvkgli
iwgallsgvadl
faflaaipsils
identifi
e
validu
venom
gland
cdna
librari
chemic
synthes
peptid
synthes
studi
prepar
chinapeptid
compani
lead
supplier
synthet
peptid
china
briefli
peptid
synthes
use
solidphas
synthesi
ctermin
amid
standard
process
fmocrink
resin
use
synthesi
resin
fmoc
strategi
piperidin
use
deprotect
hobthbtu
use
coupl
finish
peptid
cleav
resin
use
trifluoroacet
acid
tfa
precipit
ether
subject
purif
reversephas
hplc
hydrophob
resin
elitehplc
tfa
use
acetonitril
gradient
puriti
final
materi
verifi
reversephas
hplc
mass
peptid
determin
mass
spectrometri
voyagerdestr
appli
biosystem
peptid
puriti
greater
african
green
monkey
kidney
cell
vero
cultur
co
minimum
essenti
medium
mem
invitrogen
foster
ca
usa
contain
volvol
fetal
bovin
serum
fb
gibco
foster
ca
usa
uml
penicillin
streptomycin
sigma
st
loui
mo
usa
cell
infect
cultur
mem
fb
environ
describ
hightit
stock
f
strain
prepar
follow
origin
viral
stock
dilut
mem
inocul
confluent
vero
cell
cultur
multipl
infect
moi
flask
corn
new
york
usa
cytopath
effect
cpe
reach
infect
monolay
harvest
subject
three
freezethaw
cycl
use
dri
iceethanol
bath
centrifug
g
min
supernat
collect
centrifug
titrat
viru
aliquot
store
vero
cell
plant
plate
cell
per
well
cultur
h
cell
cultur
medium
replac
fresh
medium
contain
candid
peptid
seri
concentr
plate
incub
anoth
h
afterward
mtt
solut
mgml
phosphat
buffer
salin
pb
ad
well
plate
incub
h
medium
remov
dimethyl
sulfoxid
dmso
ad
well
plate
shaken
gentli
min
room
temperatur
complet
dissolv
crystal
purpl
formazan
absorb
measur
nm
use
micropl
reader
biotek
winooski
vt
usa
human
erythrocyt
obtain
fresh
human
blood
centrifug
min
g
wash
three
time
hepe
buffer
erythrocyt
resuspend
normal
salin
seed
plate
cell
per
well
peptid
ad
seri
concentr
use
posit
control
normal
salin
use
neg
control
plate
incub
h
supernat
collect
centrifug
g
min
absorb
hemoglobin
wavelength
nm
measur
use
micropl
reader
biotek
winooski
vt
usa
hemolysi
assay
approv
medic
ethic
committe
wuhan
univers
sixwel
plate
contain
confluent
vero
cell
monolay
infect
dilut
seri
aliquot
incub
h
inocula
remov
cell
wash
three
time
pb
replenish
mainten
cover
layer
mem
fb
carboxymethylcellulos
incub
period
h
cell
stain
crystal
violet
contain
methanol
plaqu
number
visual
viral
titer
plaqueform
unit
pfu
calcul
accord
plaqu
number
dilut
ratio
detail
antivir
assay
describ
section
vero
cell
monolay
plate
sixwel
plate
infect
aliquot
yield
approxim
plaqu
per
well
peptid
dissolv
pure
water
seri
concentr
scorpionderiv
antivir
peptid
screen
measur
antivir
activ
peptid
ad
seri
concentr
dilut
peptid
deriv
ad
seri
concentr
dilut
measur
antivir
activ
time
addit
experi
well
confoc
microscop
spot
flow
cytometri
analys
peptid
use
concentr
isometr
steril
water
use
neg
control
experi
antivir
assay
perform
five
differ
way
treatment
incub
deriv
peptid
directli
h
vero
cell
infect
mixtur
h
rins
replenish
cover
layer
contain
peptid
vero
cell
treat
deriv
peptid
h
rins
prior
infect
vero
cell
preincub
h
peptid
ad
simultan
cell
incub
h
cell
rins
pb
three
time
replenish
cover
layer
vero
cell
preincub
h
ad
cell
cultur
medium
incub
h
cell
rins
pb
three
time
cultur
fresh
medium
contain
peptid
h
cell
rins
pb
three
time
replenish
cover
layer
vero
cell
infect
h
cell
rins
cultur
medium
replac
cover
layer
contain
treatment
infect
h
vero
cell
rins
pb
three
time
replenish
cover
layer
inhibitori
effect
determin
plaqu
reduct
assay
pra
addit
h
secondari
structur
deriv
peptid
measur
circular
dichroism
cd
spectroscopi
measur
perform
uv
rang
nm
water
tfe
use
spectropolarimet
concentr
mgml
peptid
spectra
collect
three
separ
record
averag
subtract
blank
spectrum
pure
water
intracellular
activ
peptid
evalu
assess
infect
dna
content
intracellular
progeni
viru
vero
cell
infect
moi
h
cell
wash
replenish
mem
contain
correspond
peptid
cell
cultur
supernat
harvest
h
infect
intracellular
virus
collect
use
freezethaw
method
extracellular
intracellular
infect
assess
plaqueform
assay
dna
content
quantifi
realtim
pcr
total
dna
extract
use
minibest
viral
rnadna
extract
kit
takara
minamikusatsu
station
jpn
elut
distil
water
realtim
pcr
perform
use
sybr
green
pcr
assay
kit
system
forward
primer
sequenc
revers
primer
sequenc
pcr
product
subject
melt
curv
analysi
confirm
amplif
specif
vero
cell
incub
nterminu
fitclabel
peptid
h
afterward
cell
wash
pb
fix
paraformaldehyd
rins
twice
pb
cell
nuclei
stain
dapi
dilut
pb
min
cell
rins
six
time
pb
peptid
cellular
local
analyz
confoc
microscopi
vero
cell
treat
nterminu
fitclabel
peptid
h
cell
harvest
trypsin
wash
six
time
pb
averag
fitc
intens
cell
measur
flow
cytometri
data
express
mean
standard
deviat
least
three
separ
experi
six
put
peptid
venom
cdna
librari
scorpion
e
validu
identifi
candid
antimicrobi
peptid
bioinformat
analysi
sequenc
well
evalu
amphipathi
posit
charg
structur
classic
structur
featur
antimicrobi
peptid
precursor
structur
analysi
six
scorpionderiv
peptid
shown
figur
detail
openread
frame
amino
acid
sequenc
shown
candid
peptid
screen
viral
inactiv
plaqu
reduct
assay
pra
vero
cell
shown
figur
compar
five
candid
peptid
exert
signific
inhibitori
activ
plaqu
format
clear
almost
plaqu
control
group
set
averag
amount
plaqu
group
shown
percentag
figur
exert
plaqu
clearanc
concentr
sequenc
align
scorpion
peptid
perform
use
genedoc
softwar
figur
assess
whether
suitabl
develop
candid
agent
cytotox
vero
cell
determin
mtt
assay
figur
vero
cell
treat
seri
concentr
rang
incub
h
cytotox
concentr
vero
cell
treatment
cell
viabil
peptidetr
vero
cell
greater
hemolysi
assay
show
cell
viabil
erythrocyt
also
concentr
less
figur
data
indic
less
minim
cytotox
vero
cell
suitabl
experi
hemolyt
activ
evalu
human
erythrocyt
hemolyt
assay
concentr
also
rang
hemolysi
rate
human
erythrocyt
less
concentr
high
determin
exact
step
life
cycl
inhibit
time
addit
experi
perform
vero
cell
incub
differ
period
time
inhibitori
effect
measur
pra
figur
preincub
follow
addit
cell
attach
step
exhibit
potent
inhibit
plaqu
format
suggest
initi
inhibitori
activ
infect
contrari
scarc
reduc
plaqu
quantiti
preincub
vero
cell
ad
cell
infect
show
weak
inhibit
viral
entri
result
suggest
exert
viral
inactiv
effect
prevent
initi
infect
affect
intracellular
activ
c
timedepend
inactiv
activ
peptid
pfuwel
directli
incub
peptid
serial
durat
mixtur
appli
plaqu
reduct
assay
vero
cell
inhibitori
activ
peptid
viral
attach
ad
cell
cultur
medium
seri
concentr
simultan
viral
attach
step
rins
viral
entri
inhibitori
effect
measur
plaqu
reduct
assay
e
inhibitori
activ
peptid
viral
entri
step
viral
attach
ad
coincub
cell
viral
entri
step
inhibitori
effect
measur
plaqu
reduct
assay
f
cellular
local
peptid
vero
cell
label
fitc
cellular
local
determin
confoc
microscopi
incub
h
vero
cell
scale
bar
figur
incub
seri
concentr
mixtur
use
infect
vero
cell
data
pra
experi
show
plaqu
format
inhibit
dosedepend
manner
inhibit
concentr
viral
inactiv
effect
also
timedepend
figur
treat
min
pfu
decreas
suggest
rapidonset
inactiv
treatment
min
averag
reduct
increas
reduct
min
almost
follow
treatment
h
investig
inhibitori
activ
vero
cell
treat
seri
concentr
viral
attach
entri
step
similar
viral
inactiv
inhibitori
activ
viral
attach
also
dosedepend
figur
also
show
weak
inhibit
viral
entri
inhibit
rate
figur
therefor
show
dosedepend
timedepend
inhibit
plaqu
format
viral
inactiv
step
dosedepend
inhibit
viral
attach
addit
compar
vero
cell
select
index
si
viral
inactiv
step
viral
attach
step
tabl
consid
signific
differ
extracellular
intracellular
activ
specul
may
possess
low
cellular
uptak
vero
cell
andor
unfavor
intracellular
local
shown
figur
vero
cell
incub
fitclabel
h
examin
confoc
microscopi
result
show
fitclabel
hardli
enter
vero
cell
poor
cellular
uptak
possibl
explain
low
intracellular
activ
structur
model
use
swiss
pdb
viewer
softwar
show
adopt
structur
verifi
circular
dichroism
cd
spectroscopi
figur
result
cd
spectroscopi
reveal
adopt
structur
tfe
random
coil
structur
water
exhibit
amphipath
helic
wheel
divid
hydrophob
face
hydrophil
face
figur
data
indic
amphipath
peptid
molecul
structur
report
artifici
modifi
histidinerich
amphipath
peptid
exhibit
effici
dna
deliveri
mammalian
cell
presenc
histidin
residu
welldefin
hydrophob
face
identifi
determin
peptid
deliveri
effici
modif
scorpionderiv
antihcv
peptid
histidinerich
deriv
peptid
also
significantli
enhanc
bioavail
antihcv
activ
refer
design
strategi
sever
histidin
residu
ad
deriv
peptid
name
figur
figur
figur
figur
secondari
structur
deriv
peptid
predict
determin
use
swiss
pdb
viewer
softwar
circular
dichroism
cd
spectroscopi
figur
respect
addit
histidin
residu
disrupt
pattern
stabil
secondari
structur
amphiphil
enhanc
sequenc
align
deriv
peptid
shown
figur
cytotox
deriv
peptid
vero
cell
evalu
mtt
assay
figur
cc
valu
respect
indic
lower
cytotox
wild
type
peptid
deriv
mode
action
deriv
peptid
identifi
time
addit
experi
describ
previous
figur
four
deriv
peptid
maintain
inhibitori
activ
prolifer
preincub
ad
cell
viral
attach
step
addit
deriv
peptid
show
greater
inhibit
viral
entri
wild
type
peptid
interestingli
deriv
peptid
also
reduc
plaqu
format
pra
experi
ad
cell
infect
inhibitori
rate
respect
wherea
wild
type
peptid
hardli
exert
effect
viral
inactiv
capabl
deriv
peptid
test
viral
inactiv
four
deriv
peptid
also
dosedepend
valu
respect
significantli
lower
wild
type
peptid
figur
si
four
deriv
peptid
respect
tabl
deriv
peptid
show
rapid
inactiv
timedepend
experi
compar
wild
type
peptid
figur
particular
reduc
pfu
incub
inhibitori
activ
deriv
peptid
ad
cell
attach
entri
step
also
evalu
figur
valu
viral
attach
step
respect
also
significantli
decreas
wild
type
peptid
si
deriv
peptid
respect
tabl
valu
viral
entri
step
respect
inhibitori
activ
deriv
peptid
viral
entri
step
significantli
improv
compar
wild
type
peptid
tabl
suppress
activ
deriv
peptid
prolifer
postentri
assay
determin
figur
extracellular
intracellular
infect
assess
plaqu
form
assay
intracellular
dna
quantiti
measur
realtim
pcr
wild
type
peptid
exert
effect
wherea
extracellular
intracellular
infect
significantli
decreas
four
deriv
peptid
among
peptid
exhibit
strongest
inhibit
reduc
infect
extracellular
intracellular
respect
concentrationdepend
inactiv
activ
deriv
peptid
pfuwel
directli
treat
peptid
vero
cell
infect
viruspeptid
mixtur
serial
final
concentr
deriv
peptid
timedepend
inactiv
activ
deriv
peptid
peptid
ad
pfuwel
incub
seri
indic
durat
mixtur
use
infect
vero
cell
plaqu
reduct
assay
complet
e
inhibitori
activ
peptid
ad
cell
viral
attach
step
peptid
ad
cultur
medium
vero
cell
simultan
incub
h
cell
rins
replenish
cover
layer
plaqu
reduct
assay
complet
f
inhibitori
activ
peptid
viral
entri
cell
incub
h
wash
deriv
peptid
ad
incub
h
cell
rins
replenish
cover
layer
inhibitori
rate
measur
plaqu
reduct
assay
g
activ
deriv
peptid
postentri
step
extracellular
intracellular
infect
level
assess
plaqu
form
assay
dna
content
assess
realtim
pcr
h
flow
cytometri
measur
cellular
uptak
peptid
vero
cell
incub
fitclabel
h
averag
fitc
intens
cell
measur
flow
cytometri
p
confoc
microscop
examin
cellular
local
label
fitc
use
treat
vero
cell
h
cellular
local
determin
use
confoc
microscopi
scale
bar
determin
whether
intern
deriv
peptid
promot
addit
histidin
residu
label
fitc
incub
vero
cell
h
cellular
uptak
local
measur
flow
cytometri
confoc
microscopi
shown
figur
figur
promot
signific
cellular
uptak
dispers
distribut
compar
wild
type
peptid
past
decad
mani
antivir
peptid
discov
design
exert
potenti
virucid
activ
howev
greatest
difficulti
treat
viral
diseas
clearanc
establish
infect
natur
clinic
condit
howev
lipophil
muramyl
peptid
mtppe
report
potent
inhibitor
hiv
replic
macrophag
rabbit
simultan
prevent
entri
intercellular
spread
deriv
virucid
peptid
exhibit
antivir
activ
hcv
disturb
viral
membran
addit
block
viral
entri
suppress
establish
infect
group
also
complet
sever
studi
antivir
peptid
inhibit
establish
viral
infect
antihbv
experi
demonstr
scorpionderiv
short
linear
peptid
inhibit
hbv
replic
vitro
vivo
activ
mapk
pathway
downregul
express
design
histidinerich
peptid
templat
scorpion
venom
peptid
show
consider
inhibit
hcv
rna
ad
h
h
h
infect
scorpion
defensin
inhibit
hbv
replic
vitro
also
show
ionchannel
block
activ
antibacteri
activ
anoth
studi
us
studi
screen
cdna
librari
scorpion
venom
gland
identifi
six
scorpion
venom
peptid
amino
acid
length
antimicrobi
candid
viral
inactiv
activ
six
scorpion
venom
peptid
screen
pra
assay
contain
amino
acid
residu
clear
almost
pfu
cytotox
hemolysi
activ
test
result
show
minim
toxic
concentr
furthermor
show
signific
dosedepend
inhibit
preincub
ad
viral
attach
step
valu
respect
unfortun
scarc
exhibit
inhibit
plaqu
format
preincub
cell
infect
ad
cell
infect
addit
exert
weak
inhibit
ad
cell
viral
entri
step
result
confoc
microscopi
flow
cytometri
analys
show
exert
extrem
poor
cellular
uptak
visibl
fitclabel
detect
incub
cell
variou
method
employ
overcom
limit
surround
intracellular
amp
antivir
activ
exampl
addit
damino
acid
fluorin
amino
acid
may
enhanc
peptid
transmembran
deliveri
presenc
lysosomotrop
agent
introduct
histidin
residu
enhanc
transfect
effici
vehicl
peptid
well
amp
cellular
uptak
antivir
abil
previou
studi
group
glycin
residu
prolin
residu
scorpion
venom
deriv
peptid
mucroporin
replac
lysin
residu
arginin
residu
respect
enhanc
net
posit
charg
hydrophil
side
molecul
modif
exhibit
stronger
virucid
activ
addit
inhibit
hbv
replic
vitro
vivo
anoth
scorpionderiv
peptid
scorpion
c
tryznai
modifi
histidinerich
mutant
peptid
overcom
barrier
cellular
uptak
endosom
escap
modif
significantli
enhanc
antihcv
activ
cellular
uptak
introduc
inhibit
establish
viral
infect
studi
design
modifi
four
histidinerich
deriv
peptid
introduc
histidin
residu
four
deriv
peptid
exhibit
structur
wildtyp
peptid
indic
addit
histidin
residu
affect
peptid
structur
enhanc
helic
addit
four
deriv
peptid
show
improv
virucid
effect
valu
respect
block
activ
four
deriv
peptid
viral
attach
also
improv
valu
enhanc
respect
abil
deriv
peptid
inhibit
viral
entri
also
significantli
improv
compar
addit
deriv
peptid
show
addit
inhibit
establish
infect
ad
cell
h
infect
worth
note
histidin
residu
introduc
exhibit
significantli
reduc
cytotox
compar
deriv
peptid
cc
also
show
rapid
action
clear
pfu
incub
min
ic
inactiv
attach
respect
therefor
si
significantli
enhanc
respect
wherea
wild
type
peptid
respect
flow
cytometri
confoc
microscopi
result
show
exert
consider
cellular
uptak
dispers
distribut
may
explain
superior
antivir
activ
presenc
establish
infect
thu
introduct
histidin
residu
hydrophil
face
molecul
overcom
barrier
cellular
uptak
improv
antivir
activ
therefor
enabl
deriv
interact
intracellular
success
modif
amp
cellpenetr
peptid
cpp
previou
studi
may
provid
avenu
design
novel
activ
peptid
agent
excel
cellular
uptak
activ
modifi
previous
discov
peptid
improv
antivir
properti
howev
detail
mechan
cytotox
antivir
properti
influenc
histidin
modif
still
requir
explor
acceler
modif
optim
strategi
detail
studi
toxic
vivo
antivir
properti
deriv
peptid
need
conduct
therapeut
applic
peptid
herp
simplex
viru
type
amp
antimicrobi
peptid
cd
spectroscopi
circular
dichroism
spectroscopi
pn
peripher
nervou
system
mapk
pathway
mitogenactiv
protein
kinas
pathway
hepatocyt
nuclear
factor
tfa
trifluoroacet
acid
hplc
high
perform
liquid
chromatographi
mem
minimum
essenti
medium
fb
fetal
bovin
serum
cpe
cytopath
effect
pb
phosphat
buffer
salin
dmso
dimethyl
sulfoxid
hepe
acid
pfu
plaqueform
unit
pra
plaqu
reduct
assay
moi
multipl
infect
dapi
fitc
fluorescein
isothiocyan
cytotox
concentr
ic
inhibit
concentr
si
select
index
